Agoracom Blog Home

Posts Tagged ‘#Consumer’

Good Life Networks Property, 495 Communications, Partners with inMobi, a Mobile Advertising Company That Reaches 1.5BN Mobile Devices $TTD $RUBI $AT.ca $TRMR $FUEL

Posted by AGORACOM-Eric at 11:04 AM on Wednesday, April 24th, 2019
https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564624/hub/GLNLogo-black-11.jpg
  • 495 Communications LLC signed on inMobi, a global mobile advertising platform that reaches over 1.5 billion unique mobile devices
  • inMobi helps clients like L’Oréal, Kelloggs, Samsung and Mastercard efficiently and effectively find target consumers across mobile and tablet devices

Vancouver, British Columbia–(Newsfile Corp. – April 24, 2019) – Good Life Networks Inc. (TSXV: GOOD) (FSE: 4G5) (“GLN“, or the “Company“), a Vancouver-based programmatic advertising technology company is pleased to announce that 495 Communications LLC. (“495“), a GLN digital property, has signed on inMobi, a global mobile advertising platform that reaches over 1.5 billion unique mobile devices.
inMobi helps clients like L’Oréal, Kelloggs, Samsung and Mastercard efficiently and effectively find target consumers across mobile and tablet devices. Founded in 2007, inMobi is a global provider of enterprise platforms for marketers. The platform enables consumers to discover new products and services by providing contextual, relevant, and curated recommendations on mobile apps and devices. Their mobile-first platform allows brands, developers and publishers to engage consumers through mobile advertising.


Jesse Dylan, CEO of GLN
commented, “The success of companies like inMobi demonstrates that major brands and advertisers are looking for more effective ways to reach consumers outside of Facebook and Google, without the liability of personal identifiable information being used. The 495 team continues its exceptional performance by growing their strong network of clients.”

495 is a leading Connected Television (“CTV“), advertising and content marketing company. 495 focuses on building and developing CTV and Over the Top (“OTT“) channels for the sake of monetization and content distribution. CTV refers to any smart TV that can be connected to the internet and can stream OTT content beyond what is available from a traditional cable provider. OTT refers to any device (Roku, PlayStation, Xbox, Apple TV) that can be connected to a TV to allow for the delivery of video from the internet.

The GLN Story

GLN’s patent pending technology is the engine that sits between advertisers and publishers. A highlight of GLN’s tech is that it does not collect PII (Personal Identifiable Information). Built for cross device video advertising: Mobile, In-App, Desktop and CTV (Connected Television) the GLN Programmatic Video Advertising Platform has among the lowest fraud rates of similar vendors in the industry. Advertisers make more money by reaching their target audience more effectively. GLN makes money by retaining a percentage of the advertiser’s fee.

GLN is headquartered in Vancouver, Canada with offices in Newport Beach and Santa Monica California, New York and the United Kingdom and trades on the TSXV under the stock symbol “GOOD” and The Frankfurt Stock Exchange under the stock symbol 4G5. For further information on the Company, visit www.glninc.ca.

CONTACT

Investor Relations
[email protected]

Jesse Dylan, CEO
604 265 7511

Applied Biosciences $APPB Receives Distribution from Investment in JUUL Labs $HTIM $WMD $JUUL

Posted by AGORACOM-Eric at 11:28 AM on Tuesday, February 5th, 2019
https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564626/hub/APPB_logo.png
  • Received a capital distribution of approximately $186,000 from its investment in JUUL Labs
  • Altria Group Inc. (NYSE: MO) invested $12.8bn in vaping company Juul Labs, a (35% stake) valuing JUUL at $38 billion
  • The global e-cig and vaporizer market is one of the fastest growing consumer markets and has been recently valued at $9.0 billion and expected to grow at a CAGR of 23.6% and reach $49 billion by the end of 2024
  • APPB has a market cap of $15m US & 10m S/O

LOS ANGELES, Feb. 05, 2019 (GLOBE NEWSWIRE) — Applied BioSciences Corp. (OTCQB: APPB), a diversified cannabinoid therapeutics company focused on the medical, bioceutical and pet health industries, announced that has received a capital distribution of approximately $186,000 from its investment in JUUL Labs, Inc. (JUUL).   The company has made strategic investments in select companies they believed to be innovators in the consumer space.  The investment remains on the balance sheet under Equity Investments, but the company has begun a strategic review of options for the remaining equity stake. 

Altria Group Inc. (NYSE: MO) on December 20, 2018 announced it had invested $12.8bn in vaping company Juul Labs, a 35% stake valuing JUUL at $38 billion.  Howard Willard, Altria’s CEO said in a statement that the move was an effort to “prepare for a future where adult smokers overwhelmingly choose non-combustible products over cigarettes.” 

JUUL has become a success story and one of the fastest growing companies in the US, growing revenue to over $1 billion in a few short years.  Their brand has become synonymous with vaping and the e-cigarette market. 

The global e-cig and vaporizer market is one of the fastest growing consumer markets and has been recently valued at $9.0 billion and expected to grow at a CAGR of 23.6% and reach $49 billion by the end of 2024, according to Research Nestor (www.researchnester.com).

The company continues to make select investments in companies that can help shape the product roadmap and development of new products and potential partnerships.

About Applied BioSciences Corp.
Applied BioSciences Corp. (www.appliedbiocorp.com), is a diversified company focused on multiple areas of the medical, bioceutical and pet health industry. As a leading company in the CBD and Pet health space, the company is currently shipping to the majority of US states as well as to 5 International countries.  The company is focused on select investment, consumer brands, and partnership opportunities in the recreational, health and wellness, nutraceutical, and media industries.

About Trace Analytics Inc.
Trace Analytics Inc. is a leading cannabis science and technology company with significant footprints in lab testing, research and development and licensing. Trace Analytics was started by a group of scientists who specialized in analytical chemistry, genetics and molecular biology.  The focus of the team is to ensure compliance with public safety standards and end user safety. Trace Analytics is in the process of expanding throughout the United States, and globally. With the goal of helping the rest of the world adopt “best practices” in cannabis and hemp testing, the company also provides expert consulting services to legislators and regulators in many countries, states and municipalities around the world. For more information, please visit: http://traceanalytics.com

Contact
Email: [email protected]  or [email protected]

To be added to the Applied BioSciences email distribution list, please email [email protected] with APPB in the subject line.

Official Website:www.appliedbiocorp.com / www.traceanalytics.com

Brands:
www.remedishop.com
www.herbalpet.com
www.canagel.com

Follow us:
Facebook @remedicbd & @HerbalPetMeds
Instagram @remedishop & @herbal_pet
Twitter @remedishop & @herbal_pet